WWP2
Basic information
Region (hg38): 16:69762328-69941741
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WWP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 40 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 0 | 2 |
Variants in WWP2
This is a list of pathogenic ClinVar variants found in the WWP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-69787032-C-T | not specified | Uncertain significance (Jun 13, 2023) | ||
16-69798718-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
16-69798719-T-G | Likely benign (Sep 01, 2024) | |||
16-69798778-C-A | not specified | Uncertain significance (Dec 03, 2021) | ||
16-69798786-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
16-69798789-A-T | not specified | Uncertain significance (Apr 07, 2023) | ||
16-69798796-G-A | not specified | Uncertain significance (Jul 29, 2023) | ||
16-69799290-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
16-69840168-A-C | not specified | Uncertain significance (Oct 13, 2021) | ||
16-69840175-C-A | not specified | Uncertain significance (Mar 20, 2024) | ||
16-69840187-C-T | Likely benign (Nov 01, 2024) | |||
16-69840200-A-G | not specified | Uncertain significance (Feb 13, 2023) | ||
16-69840209-G-C | not specified | Uncertain significance (Nov 16, 2024) | ||
16-69840225-A-G | not specified | Uncertain significance (Feb 22, 2023) | ||
16-69840261-A-C | not specified | Uncertain significance (Sep 17, 2021) | ||
16-69842024-G-A | not specified | Uncertain significance (Sep 10, 2024) | ||
16-69842059-G-C | not specified | Uncertain significance (Oct 05, 2021) | ||
16-69842080-C-T | not specified | Uncertain significance (Dec 07, 2024) | ||
16-69842088-C-T | Benign (Dec 15, 2018) | |||
16-69842096-C-G | not specified | Uncertain significance (Dec 07, 2024) | ||
16-69842105-T-A | not specified | Uncertain significance (Aug 21, 2023) | ||
16-69842119-C-T | not specified | Uncertain significance (Jul 09, 2024) | ||
16-69871818-C-G | not specified | Uncertain significance (Oct 25, 2022) | ||
16-69871818-C-T | Benign (Apr 30, 2018) | |||
16-69888043-T-A | not specified | Uncertain significance (Mar 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WWP2 | protein_coding | protein_coding | ENST00000359154 | 23 | 179436 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.165 | 0.835 | 125675 | 0 | 73 | 125748 | 0.000290 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.59 | 454 | 560 | 0.810 | 0.0000362 | 5677 |
Missense in Polyphen | 187 | 285.12 | 0.65587 | 2832 | ||
Synonymous | 0.591 | 211 | 222 | 0.950 | 0.0000151 | 1670 |
Loss of Function | 5.21 | 13 | 54.5 | 0.238 | 0.00000272 | 576 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000174 | 0.000174 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00289 | 0.00289 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000887 | 0.0000879 |
Middle Eastern | 0.00289 | 0.00289 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Polyubiquitinates POU5F1 by 'Lys-63'-linked conjugation and promotes it to proteasomal degradation; in embryonic stem cells (ESCs) the ubiquitination is proposed to regulate POU5F1 protein level. Ubiquitinates EGR2 and promotes it to proteasomal degradation; in T-cells the ubiquitination inhibits activation- induced cell death. Ubiquitinates SLC11A2; the ubiquitination is enhanced by presence of NDFIP1 and NDFIP2. Ubiquitinates RPB1 and promotes it to proteasomal degradation. {ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:19651900}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Signal Transduction;Regulation of PTEN stability and activity;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH3;Signaling by NOTCH;PTEN Regulation;PIP3 activates AKT signaling;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- loftool
- 0.366
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.8
Haploinsufficiency Scores
- pHI
- 0.761
- hipred
- Y
- hipred_score
- 0.793
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.942
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wwp2
- Phenotype
- skeleton phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- wwp2
- Affected structure
- palate
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;protein polyubiquitination;cellular protein modification process;ubiquitin-dependent protein catabolic process;extracellular transport;negative regulation of gene expression;protein ubiquitination;negative regulation of transporter activity;regulation of ion transmembrane transport;regulation of membrane potential;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of DNA-binding transcription factor activity;positive regulation of protein catabolic process;negative regulation of Notch signaling pathway;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;viral entry into host cell;negative regulation of protein transport;protein autoubiquitination;protein K63-linked ubiquitination;regulation of potassium ion transmembrane transporter activity
- Cellular component
- ubiquitin ligase complex;nucleus;cytoplasm;cytosol;membrane;extracellular exosome
- Molecular function
- RNA polymerase II transcription factor binding;ubiquitin-protein transferase activity;protein binding;transcription factor binding;ubiquitin protein ligase activity